Références
1 Dechanont S, Maphanta S,
Butthum B, Kongkaew C. Hospital
admissions/visits associated
with drug–drug interactions: a
systematic review and metaanalysis.
Pharmacoepidemiol Drug
Saf. 2014;23(5):489-97.
2 Tisdale JE. Drug-induced QT
interval prolongation and torsades
de pointes: Role of the pharmacist
in risk assessment, prevention
and management. Can Pharm J.
2016;149(3):139-52.
3 Crossway, Maincare Solutions©.
4 Centricity Critical Care,
GE Healthcare©.
5 BluKanGo, Blue Medi Santé©.
6 Jhuo SJ, Tang WH, Lai WT, Lee KT.
Torsade de pointes induced by
amiodarone in a patient with
heart failure. Kaoshiung J Med
Sci. 2014;30(2):108-9.
7 Yalta K, Turgut O, Yilmaz A,
Yilmaz MB et al. Torsades de
pointes with a severely prolonged
QT interval induced by an initial low
dose sotalol intake. Int J Cardiol.
2007;116(3):e95-7.
8 Dictionnaire Vidal 2018,
94ème édition, Vidal®.
9 Charpiat B, Allenet B, Roubille R,
Escofier L et al. Facteurs à prendre
en considération pour la gestion
des interactions médicamenteuses
en pratique clinique. Presse Med.
2008;37(4,2):654-64.
10 Staff M, Roberts C, March L. The
completeness of electronic medical
record data for patients with Type 2
Diabetes in primary care and its
implications for computer modelling
of predicted clinical outcomes. Prim
Care Diabetes. 2016;10(5):352-9.
11 Danielsson B, Collin J,
Jonasdottir Bergman G,
Borg N et al. Antidepressants
and antipsychotics classified with
torsades de pointes arrhythmia risk
and mortality in older adults - a
Swedish nationwide study. Br J Clin
Pharmacol. 2015;81(4):773-83.
12 Teply RM, Packard KA, White ND,
Hilleman DE, DiNicolantonio JJ.
Treatment of Depression in
patients with concomitant cardiac
disease. Prog Cardiovasc Dis.
2016;58(5):514-28.
28 Journal de Pharmacie de Belgique - 101ème année n° 1 - mars 2019
13 Wei A, Peng J, Gu Z, Li J. QTc
prolongation and torsades de
pointes due to a coadministration
of fluoxetine and amiodarone
in a patient with implantable
cardioverter-defibrillator:
Case report and review of
the literature. Medicine.
2017;96(49):e9071.
14 Patanè S, Marte F, Di Bella G.
QT interval prolongation and
torsade de pointes. Int J Cardiol.
2009;131(2):e51-3.
15 Debouck F, Rieger E, Petit H,
Noël G, Ravinet L. Méthode
Orion® : analyse systémique
simple et efficace des
événements cliniques et des
précurseurs survenant en
pratique médicale hospitalière.
Cancer / Radiothérapie.
2012;16(3):201-8.
16 Tisdale JE, Jaynes HA,
Kingery JR, Mourad NA et al.
Development and validation of a
risk score to predict QT interval
prolongation in hospitalized
patients. Circ Cardiovasc Qual
Outcomes. 2013;6(4):479-87.
Etude Farmaceutisch Tijdschrift voor BelgFiaërmaceutisch Tijdschrift voor België